Sanuwave Health Price to Sales Ratio 2010-2024 | SNWVD

Historical PS ratio values for Sanuwave Health (SNWVD) over the last 10 years. The current P/S ratio for Sanuwave Health as of October 25, 2024 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Sanuwave Health P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
0.00 nan
Sector Industry Market Cap Revenue
Medical MED PRODUCTS $0.056B $0.020B
SANUWAVE Health, Inc. is engaged in the development and commercialization of non-invasive, biological response-activating devices for the repair and regeneration of tissue, musculoskeletal and vascular structures. The Company's product candidates include its proprietary PACE technology applicable in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions; and dermaPACE for treatment of the skin and subcutaneous soft tissue. The Company's products help in activating biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration. SANUWAVE Health, Inc. is based in Alpharetta, USA.
Stock Name Country Market Cap PE Ratio
Fanhua (AIFU) China $0.081B 1.96
Ocuphire Pharma (IRD) United States $0.031B 0.00
Top KingWin (WAI) China $0.007B 0.00
S&W Seed (SANW) United States $0.006B 0.00
Invo BioScience (NAYA) United States $0.003B 0.00